EQUILLIUM, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EQUILLIUM, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $7.00K.
- EQUILLIUM, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $91.00K, a 5.81% increase year-over-year.
- EQUILLIUM, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $86.00K, a 39.01% decline year-over-year.
- EQUILLIUM, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $141.00K, a 11.02% increase year-over-year.
- EQUILLIUM, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $160.00K, a 3.03% decline from fiscal 2023.
- EQUILLIUM, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $165.00K, a 23.26% decline from fiscal 2022.
- EQUILLIUM, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $215.00K, a 17.62% decline from fiscal 2021.
- EQUILLIUM, INC. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $261.00K, a 67.31% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $7.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $160.00K 10-K · filed 2026-03-25 | |
| 2024-06-30 | $91.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $165.00K 10-K · filed 2025-03-27 | |
| 2023-06-30 | $86.00K 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $215.00K 10-K · filed 2024-03-25 | |
| 2022-06-30 | $141.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $261.00K 10-K · filed 2023-03-23 | |
| 2021-06-30 | $127.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $156.00K 10-K · filed 2022-03-23 | |
| 2020-06-30 | $96.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $42.00K 10-K · filed 2021-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |